Company intelligence / Profile preview

ChroniSense Medical

Ownership: Private
Development stage: Commercial

Overview

ChroniSense Medical has developed the Polso™ wearable device, which has received FDA 510(k) clearance for remote patient monitoring of blood oxygen saturation (SpO2), pulse rate, and respiration rate. Clinical validation studies have demonstrated accuracy and ease of use across diverse populations. Additional parameters such as blood pressure are under development.

Therapeutic areas: OtherPulmonologyCardiovascular
Modalities: DeviceNon-pharmacological therapy (remote monitoring platform)
Industry: Physiological Monitoring

Partnerships

Collaborates with hospitals and practitioners in the U.S. and globally; specific partners not named

Beyond the preview

Go deeper on ChroniSense Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChroniSense Medical.

Explore the full profile